Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells
Giuliana Cassinelli, Valentina Zuco, Laura Gatti, et al.
Current Medicinal Chemistry (2013) Vol. 20, Iss. 15, pp. 1923-1945
Closed Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

The rediscovery of platinum-based cancer therapy
Sven Rottenberg, Carmen A. Widmer, Paola Perego
Nature reviews. Cancer (2020) Vol. 21, Iss. 1, pp. 37-50
Closed Access | Times Cited: 687
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Mark A. Feitelson, Alla Arzumanyan, Rob J. Kulathinal, et al.
Seminars in Cancer Biology (2015) Vol. 35, pp. S25-S54
Open Access | Times Cited: 649
Tissue invasion and metastasis: Molecular, biological and clinical perspectives
Wen G. Jiang, Andrew J. Sanders, Masaru Katoh, et al.
Seminars in Cancer Biology (2015) Vol. 35, pp. S244-S275
Open Access | Times Cited: 463
Molecular chess? Hallmarks of anti-cancer drug resistance
Ian A. Cree, Peter Charlton
BMC Cancer (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 286
Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
Giovanni Luca Beretta, Giuliana Cassinelli, Marzia Pennati, et al.
European Journal of Medicinal Chemistry (2017) Vol. 142, pp. 271-289
Closed Access | Times Cited: 189
Phytochemicals: Current strategy to sensitize cancer cells to cisplatin
Chao‐Yue Sun, Qian-Yu Zhang, Guangjuan Zheng, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 110, pp. 518-527
Open Access | Times Cited: 110
A multi-targeted approach to suppress tumor-promoting inflammation
Abbas Samadi, Alan Bilsland, Alexandros G. Georgakilas, et al.
Seminars in Cancer Biology (2015) Vol. 35, pp. S151-S184
Open Access | Times Cited: 104
Causal interactions from proteomic profiles: Molecular data meet pathway knowledge
Özgün Babur, Augustin Luna, Anil Korkut, et al.
Patterns (2021) Vol. 2, Iss. 6, pp. 100257-100257
Open Access | Times Cited: 75
Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A axis
Bin Zhang, Jie Li, Yijun Wang, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 3, pp. 309-321
Open Access | Times Cited: 13
Role of FoxO Proteins in Cellular Response to Antitumor Agents
Giovanni Luca Beretta, Cristina Corno, Nadia Zaffaroni, et al.
Cancers (2019) Vol. 11, Iss. 1, pp. 90-90
Open Access | Times Cited: 74
Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy
Jiahui Xu, Shilian Hu, Guodong Shen, et al.
Cancer Cell International (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 70
Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors
Mehlika Dilek Altıntop, Belgin Sever, Gülşen Akalın Çiftçi, et al.
European Journal of Medicinal Chemistry (2018) Vol. 155, pp. 905-924
Closed Access | Times Cited: 68
Synergistic effect of kaempferol and 5‑fluorouracil on the growth of colorectal cancer cells by regulating the PI3K/Akt signaling pathway
Qiongyu Li, Lihui Wei, Shan Lin, et al.
Molecular Medicine Reports (2019)
Open Access | Times Cited: 67
Regulation of pleiotropic physiological roles of nitric oxide signaling
Loshini Soundararajan, Arun Dharmarajan, G Priyanka
Cellular Signalling (2022) Vol. 101, pp. 110496-110496
Closed Access | Times Cited: 33
Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy
Mehlika Dilek Altıntop, İpek Ertorun, Gülşen Akalın Çiftçi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116698-116698
Closed Access | Times Cited: 7
Therapeutic targeting of replicative immortality
Paul Yaswen, Karen L. MacKenzie, W. Nicol Keith, et al.
Seminars in Cancer Biology (2015) Vol. 35, pp. S104-S128
Open Access | Times Cited: 64
Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models
Chaoxin Hu, Tikva Dadon, Venugopal Chenna, et al.
Molecular Cancer Therapeutics (2015) Vol. 14, Iss. 7, pp. 1532-1539
Open Access | Times Cited: 60
Akt phosphorylates Prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells
Lili Jiang, Pei Dong, Zhiyuan Zhang, et al.
Cell Death and Disease (2015) Vol. 6, Iss. 2, pp. e1660-e1660
Open Access | Times Cited: 59
Broad targeting of triptolide to resistance and sensitization for cancer therapy
Zhenyan Hou, Xiaopei Tong, Yongbo Peng, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 104, pp. 771-780
Closed Access | Times Cited: 56
Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway
Xuechao Li, Yarong Song, Peng Zhang, et al.
Tumor Biology (2015) Vol. 37, Iss. 6, pp. 7599-7613
Closed Access | Times Cited: 55
Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling pathway
Yuewen Chao, Yan Wang, Xuejiao Liu, et al.
Journal of Neuro-Oncology (2014) Vol. 121, Iss. 2, pp. 279-288
Closed Access | Times Cited: 54
Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors
Mehlika Dilek Altıntop, Belgin Sever, Gülşen Akalın Çiftçi, et al.
Molecules (2018) Vol. 23, Iss. 6, pp. 1318-1318
Open Access | Times Cited: 54
Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies
Ellen Weisberg, Atsushi Nonami, Zaoping Chen, et al.
Leukemia (2014) Vol. 29, Iss. 1, pp. 27-37
Open Access | Times Cited: 53
pH-Sensitive Nano-Complexes Overcome Drug Resistance and Inhibit Metastasis of Breast Cancer by Silencing Akt Expression
Jieying Yin, Tianqun Lang, Dongmei Cun, et al.
Theranostics (2017) Vol. 7, Iss. 17, pp. 4204-4216
Open Access | Times Cited: 50
Synthesis, In Silico and In Vitro Assessment of New Quinazolinones as Anticancer Agents via Potential AKT Inhibition
Ahmed A. Noser, Mohamed El-Naggar, Thoria Donia, et al.
Molecules (2020) Vol. 25, Iss. 20, pp. 4780-4780
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top